“Comparison of Empagliflozin-Linagliptin with Empagliflozin- Metformin Combination Therapy in Assessing Cardiovascular Profile and Anemia in Type 2 Diabetic Patients”, J. Bahria Univ. Med. Dent. Coll., vol. 15, no. 04, pp. 282–287, Oct. 2025, doi: 10.51985/JBUMDC2025572.